Bindinglaw

US · guidance

CMS Pub. 100-10, ch. 9, § 9130.2

QIO Physician Review Process Description

activein force · 2026-08-25 – presentas-observed

The QIO will conduct a 5-day review when the Regional Office DSC requests. The QIO

physician peer reviewer will:

1. Provide his/her clinical assessment of the case based solely on the documentation

the CMS Regional Office DSC provides;

2. Not state whether an EMTALA violation occurred; and

3. Complete the necessary paperwork, including:

• EMTALA Physician Review Document Checklist (Appendix 9-11); and

• EMTALA Physician Review Worksheet (Appendix 9-12).

NOTE: It is NOT permissible for the QIO to offer a meeting to discuss the EMTALA

review case with the hospital and/or practitioner(s). If the QIO physician reviewer needs

additional information, the QIO is to communicate directly with the CMS Regional Office

DSC that assigned the case.

The QIO must forward the original EMTALA Physician Review Worksheet (Appendix 9-

12) provided by the Regional Office DSC to the QIO physician peer reviewer for

completion.

• The QIO can use the Physician Reviewer Worksheet provided by DSC as an

original form to be completed by the Physician Reviewer. In addition, the QIO

physician reviewer MUST include a legibly written (if not completed

electronically) response and complete rationale for EACH question on the

EMTALA Physician Review Worksheet. (See Appendix 9-12.)

NOTE: CMS highly recommends that the QIO Physician Reviewer be well

versed on key regulatory definitions, such as “emergency medical condition” and

“stabilized” as well as the criteria for appropriate EMTALA medical screening

examinations and transfers. (The QIO must provide all reviewers with the link to

CMS’s interpretive guidelines explaining the EMTALA requirements in detail and

encourage reviewers to consult this guidance when they have questions about any

aspects of the Physician Review Worksheet. This guidance is available at:

http://cms.hhs.gov/Regulations-and-

Guidance/Guidance/Manuals/downloads/som107ap_v_emerg.pdf.) The QIO

should enter the physician reviewer responses from the EMTALA Physician

Review Worksheet (Appendix 9-12) verbatim into the CMS-designated review

system if available, and keep a file copy for their records in accordance with

record keeping requirements.

• The QIO MUST NOT change the physician reviewer response unless the

physician reviewer gives his/her approval. approval should be noted on the

original EMTALA Physician Review Worksheet.

• A copy of the original EMTALA Physician Review Worksheet (with the physician

reviewer’s name redacted) should be forwarded to the CMS Regional Office DSC.

NOTE: See the EMTALA Physician Review Document Checklist (Appendix 9-11) for a

complete list of documents that the QIO physician peer reviewer reviewed. This checklist

MUST be sent to the Regional Office DSC upon review completion.

When completing the EMTALA Physician Review Worksheet (Appendix 9-12), the QIO

physician reviewer should NOT provide a statement or opinion on either of the following:

• His or her opinion as to whether an EMTALA violation occurred; and/or

• Other observations about the case that are not specifically asked to be addressed

(e.g., personal comments regarding the case).

The criteria for an acceptable EMTALA physician review are as follows:

1. The review must meet all timeliness, administrative, and clinical requirements; and

2. The review must be consistent with:

• Accepted standards of medical practice;

• EMTALA statutory definitions;

• Evidence-based clinical standards; and

• Sound clinical judgment.

If the CMS Regional Office DSC identifies an administrative concern with the EMTALA

Physician Review Worksheet, the DSC will make a request to correct the issues. This may

involve a direct discussion between the QIO and DSC Regional Office.

NOTE: A concern with the EMTALA Physician Review Worksheet is considered

administrative when the review is incomplete, unclear, internally inconsistent, and/or

suggests an apparent lack of understanding of the EMTALA standards that govern the

review.

If the CMS Regional Office DSC identifies a concern with the clinical components of the

review, then the DSC representative, CMS designated representative, and COR will

discuss the case. As a result of this discussion, one or more of the following may occur:

1. The QIO COR will ask for a re-review by the same physician reviewer, or

2. The QIO COR will ask for a re-review (which would be the second re-review if the

same physician who did the initial review has already conducted a re-review) by a

completely new QIO physician reviewer.

NOTE: A concern is considered clinical when the opinion rendered appears biased, does

not follow accepted standards of medical practice, or addresses issues outside the expert

competency of the QIO physician reviewer.

History

(Rev. 24, Issued: 02-12-16, Effective: 03-14-16, Implementation: 03-14-16)

Provenance

Source
cms.gov
Retrieved
2026-08-25
Edition
iom-2026-08-25
Content hash
06eeaf0ce2496391186f9ccb6dfcf4786a76fc23158da3a74f4737c728048eba
View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs

Bindinglaw

Point-in-time US law with the receipt attached. Source URL, retrieval time, content hash, and validity dates on every answer.

curl api.binding.law/v1/law/coverage

© 2026 binding.law · a Jubal, Inc. productAttorneys and firms never pay. Ever.